Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis

Andrea Becker-Merok, Manar Kalaaji, Kaia Haugbro, Cathrin Nikolaisen, Kirsten Nilsen, Ole Petter Rekvig, Johannes C. Nossent

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

This study investigated the overall clinical impact of anti-α- actinin antibodies in patients with pre-selected autoimmune diseases and in a random group of anti-nuclear antibody (ANA)-positive individuals. The relation of anti-a-actinin antibodies with lupus nephritis and anti-double-stranded DNA (anti-dsDNA) antibodies represented a particular focus for the study. Using a cross-sectional design, the presence of antibodies to α-actinin was studied in selected groups, classified according to the relevant American College of Rheumatology classification criteria for systemic lupus erythematosus (SLE) (n = 99), rheumatoid arthritis (RA) (n = 68), Wegener's granulomatosis (WG) (n = 85), and fibromyalgia (FM) (n = 29), and in a random group of ANA-positive individuals (n = 142). Renal disease was defined as (increased) proteinuria with haematuria or presence of cellular casts. Sera from SLE, RA, and Sjøgren's syndrome (SS) patients had significantly higher levels of anti-α-actinin antibodies than the other patient groups. Using the geometric mean (± 2 standard deviations) in FM patients as the upper cutoff, 20% of SLE patients, 12% of RA patients, 4% of SS patients, and none of the WG patients were positive for anti-α-actinin antibodies. Within the SLE cohort, anti-α-actinin antibody levels were higher in patients with renal flares (p = 0.02) and correlated independently with anti-dsDNA antibody levels by enzyme-linked immunosorbent assay (p < 0.007) but not with other disease features. In the random ANA group, 14 individuals had anti-α-actinin antibodies. Of these, 36% had SLE, while 64% suffered from other, mostly autoimmune, disorders. Antibodies binding to α-actinin were detected in 20% of SLE patients but were not specific for SLE. They correlate with anti-dsDNA antibody levels, implying in vitro crossreactivity of anti-dsDNA antibodies, which may explain the observed association with renal disease in SLE.

Original languageEnglish
Article numberR162
JournalArthritis Research and Therapy
Volume8
Issue number6
DOIs
Publication statusPublished - 24 Oct 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis'. Together they form a unique fingerprint.

Cite this